Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data

BACKGROUND: Antimuscarinics (AMs) represent the mainstay of treatment for storage lower urinary tract symptoms (LUTS) but few data are available on their impact in multiple sclerosis (MS) patients. OBJECTIVE: To assess effectiveness and tolerability of AMs in MS patients with neurogenic detrusor ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Andretta, Elena, Finazzi Agrò, Enrico, Calabrese, Massimiliano, Orecchia, Luca, Furlan, Antonietta, Zuliani, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Therapeutic Advances in Neurogenic Bladder Dysfunction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510970/
https://www.ncbi.nlm.nih.gov/pubmed/36172491
http://dx.doi.org/10.1177/17562872221122484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510970/
https://www.ncbi.nlm.nih.gov/pubmed/36172491
http://dx.doi.org/10.1177/17562872221122484

Ejemplares similares